RT Journal Article SR Electronic T1 T-bet+ CD11c+ B cells are critical for anti-chromatin IgG production in the development of lupus JF bioRxiv FD Cold Spring Harbor Laboratory SP 116145 DO 10.1101/116145 A1 Ya Liu A1 Shiyu Zhou A1 Jie Qian A1 Yan Wang A1 Xiang Yu A1 Dai Dai A1 Min Dai A1 Lingling Wu A1 Zhuojun Liao A1 Zhixin Xue A1 Jiehua Wang A1 Guojun Hou A1 Jianyang Ma A1 John B. Harley A1 Yuanjia Tang A1 Nan Shen YR 2017 UL http://biorxiv.org/content/early/2017/03/12/116145.abstract AB A hallmark of systemic lupus erythematosus is high titers of circulating autoantibody. A novel CD11c+ B cell subset has been identified that is critical for the development of autoimmunity. However, the role of CD11c+ B cells in the development of lupus is unclear. Chronic graft-versus-host disease (cGVHD) is a lupus-like syndrome with great autoantibody production. In the present study we investigated the role of CD11c+ B cells in the pathogenesis of lupus in the cGVHD model. Here, we found the percentage and absolute number of CD11c+ B cells and titer of sera anti-chromatin IgG and IgG2a antibody were increased in cGVHD mice. CD11c+ plasma cells from cGVHD mice produced large amounts of anti-chromatin IgG2a upon stimulation. Depletion of CD11c+ B cells reduced anti-chromatin IgG and IgG2a production. T-bet expression was further shown to be upregulated in CD11c+ B cells. Knockout of T-bet in B cells alleviated cGVHD. The percentage of T-bet+ CD11c+ B cells was elevated in lupus patients and positively correlated with serum anti-chromatin levels. Our findings suggest T-bet+ CD11c+ B cells contribute to the pathogenesis of lupus and provides potential target for therapeutic intervention.